Search IconSearch

Tag: peter anderson

23-CHP-3770312 CQD Anderson – Chemotherapy and Radiation Toxicities
June 8, 2023/Cancer

Strategies to Reduce Cancer Therapy Toxicities and Improve Eating Habits

Complex, bidirectional interactions exist between cancer, therapy, toxicities and eating behaviors

August 8, 2022/Cancer

Radium Knocks Out Tumor Cells in Case of Unresectable Paraspinal Osteosarcoma

The decision to use 223-radium, and an outcome that exceeded expectations

March 10, 2022/Cancer

ONC201 and Neuroendocrine Tumors: Promising Findings From a Phase II Trial

New findings about the drug’s safety and efficacy from a phase II trial

August 12, 2021/Cancer

Treating a Rare Ewing Sarcoma Case With Patience and Persistence

Slight deviation from treatment paradigm salvages significant anatomy


Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

June 8, 2021/Cancer

New Drug Holds Promise for Rare Neuroendocrine Tumors

Data from Phase 2 study of ONC201 to be presented at ASCO

March 24, 2016/Cancer

Boosting Effectiveness of Radiation Against Childhood Cancers

Pursuing New Medicines and Paradigms

December 24, 2015/Cancer

Introducing Pediatric Hematologist-Oncologist Peter Anderson, MD, PhD

Clinician-researcher is a globally recognized osteosarcoma expert

BackPage 1 of 1Next